NVP Associates, LLC
NVP Associates, LLC reported 7 US-listed holdings worth $328.2 million in its 13F for the quarter ended 30 June 2026, filed 7 August 2026. Its largest: MBX Biosciences Inc. (35.9%), Avalyn Pharma Inc. (22.8%) and Omada Health Inc. (16.9%). Against the quarter before, it opened 3 positions, added to 0, trimmed 0 and sold out of 1.
The 7 largest of its 7 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned +330.6% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it did on the quarter
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 3
- Avalyn Pharma Inc. AVLN$74.7 million
- Snowflake Inc. SNOW$29.2 million
- Ondas Hldgs Inc. ONDS$128,560
Sold out of 1
- Billiontoone Inc. BLLN$40.5 million last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| MBX Biosciences Inc. MBX | 2.1M | $117.9 million | 35.93% | no change |
| Avalyn Pharma Inc. AVLN | 2.3M | $74.7 million | 22.75% | new |
| Omada Health Inc. OMDA | 2.5M | $55.6 million | 16.93% | no change |
| Zenas Biopharma Inc. ZBIO | 1.8M | $46.7 million | 14.22% | no change |
| Snowflake Inc. SNOW | 114.8K | $29.2 million | 8.90% | new |
| Grove Collaborative Hold Inc. GROV | 3.2M | $4.0 million | 1.23% | no change |
| Ondas Hldgs Inc. ONDS | 15.6K | $128,560 | 0.04% | new |